Wand, Gary S <br/><br/>
The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade.  [electronic resource] 

 -  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology  Jan 2002 
 - 106-14 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0893-133X 
<br/><br/><label>Standard No.: </label>10.1016/S0893-133X(01)00294-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Amino Acid Substitution<br/>Carrier Proteins--drug effects<br/>DNA--genetics<br/>Electrophoresis, Polyacrylamide Gel<br/>Hormones--blood<br/>Humans<br/>Hypothalamo-Hypophyseal System--drug effects<br/>Male<br/>Membrane Glycoproteins--drug effects<br/>Membrane Transport Proteins<br/>Mutation--physiology<br/>Naloxone--pharmacology<br/>Narcotic Antagonists--pharmacology<br/>Nerve Tissue Proteins<br/>Personality<br/>Polymorphism, Genetic--genetics<br/>Protein Denaturation<br/>Receptors, Opioid--genetics<br/>Receptors, Opioid, mu--genetics<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Serotonin Plasma Membrane Transport Proteins